Concepedia

Be‐Sheng Kuo

BK

10

Publications

348

Citations

10

H-Index

1988

Active since

Affiliations

Thomas Jefferson University(Current)

Duke Medical Center

Asia University

National Taiwan University Hospital

Be‐Sheng Kuo is an author at Thomas Jefferson University specializing in medicine, pharmacology, and natural sciences.

Top concepts

Publications per year

1988–2022

10

Publications

10

UB‐311, a novel UBITh <sup>®</sup> amyloid β peptide vaccine for mild Alzheimer's disease

Chang Yi Wang, Pei‐Ning Wang, Ming‐Jang Chiu et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2017 · 139 citations · Full text

The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret

Lakhbir Singh, Mark J. Field, John Hughes et al. · European Journal of Pharmacology · 1997 · 54 citations

, , +4

IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms

Be‐Sheng Kuo, Chao-Hung Li, Jiun-Bo Chen et al. · Journal of Clinical Investigation · 2022 · 50 citations · Full text

Column-switching high-performance liquid chromatographic (HPLC) determination of hydrochlorothiazide in rat, dog, and human plasma.

Be‐Sheng Kuo, Arun K. Mandagere, David R. Osborne et al. · Pharmaceutical Research · 1990 · 20 citations

, , +8

Effects of sulfonylureas on the synthesis and secretion of plasminogen activator from bovine aortic endothelial cells.

Be‐Sheng Kuo, Gil Korner, T D Bjornsson · Journal of Clinical Investigation · 1988 · 20 citations · Full text

, , +19

Rows per page

1–5 of 10